title: Overeating Behavior and Striatal Dopamine with 6-[F]-Fluoro-L-m-Tyrosine PET.
abstract: Eating behavior may be affected by dopamine synthesis capacity. In this study, 6-[(18)F]-fluoro-L-m-tyrosine (FMT) positron emission tomography (PET) uptake in striatal subregions was correlated with BMI (kg/m(2)) and an estimate of the frequency of prior weight loss attempts in 15 healthy subjects. BMI was negatively correlated with FMT uptake in the dorsal caudate. Although the association between BMI and FMT uptake in the dorsal caudate was not significant upon correction for age and sex, the association fell within the range of a statistical trend. Weight loss attempts divided by years trying was also negatively correlated with FMT uptake in the dorsal putamen (P = .05). These results suggest an association between low dorsal striatal presynaptic dopamine synthesis capacity and overeating behavior.
authors.affiliation: Department of Psychiatry, University of California at San Francisco, 401 Parnassus Avenue, San Francisco, CA 94143, USA.
authors.forename: Claire E
authors.initials: CE
authors.lastname: Wilcox
authors.forename: Meredith N
authors.initials: MN
authors.lastname: Braskie
authors.forename: Jennifer T
authors.initials: JT
authors.lastname: Kluth
authors.forename: William J
authors.initials: WJ
authors.lastname: Jagust
references.citation: Am J Psychiatry. 2005 Aug;162(8):1515-20
references.pmid: 16055774
references.citation: Mol Psychiatry. 1998 Mar;3(2):156-61
references.pmid: 9577840
references.citation: Expert Opin Ther Targets. 2002 Oct;6(5):601-9
references.pmid: 12387683
references.citation: Synapse. 2007 Sep;61(9):748-56
references.pmid: 17568412
references.citation: Biol Psychiatry. 2002 Oct 1;52(7):759-63
references.pmid: 12372667
references.citation: J Nucl Med. 1999 Dec;40(12):2053-65
references.pmid: 10616886
references.citation: J Neurosci. 2007 Nov 14;27(46):12700-6
references.pmid: 18003850
references.citation: J Addict Dis. 2004;23(3):39-53
references.pmid: 15256343
references.citation: Neuroimage. 2003 Aug;19(4):1709-15
references.pmid: 12948725
references.citation: Obes Res. 2004 Jun;12(6):929-35
references.pmid: 15229331
references.citation: Neuroreport. 2001 Nov 16;12(16):3549-52
references.pmid: 11733709
references.citation: Neuroimage. 2004 Dec;23(4):1486-93
references.pmid: 15589112
references.citation: J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57
references.pmid: 11524609
references.citation: Trends Neurosci. 2007 Aug;30(8):375-81
references.pmid: 17604133
references.citation: Neuroimage. 2007 Aug 15;37(2):410-21
references.pmid: 17566768
references.citation: Addict Behav. 1982;7(1):47-55
references.pmid: 7080884
references.citation: Synapse. 2002 Jun 1;44(3):175-80
references.pmid: 11954049
references.citation: J Cereb Blood Flow Metab. 1985 Dec;5(4):584-90
references.pmid: 4055928
references.citation: Br J Pharmacol. 1994 May;112(1):23-30
references.pmid: 7913379
references.citation: J Psychiatr Res. 2009 Apr;43(7):687-96
references.pmid: 19041097
references.citation: Biol Psychiatry. 2005 Nov 15;58(10):779-86
references.pmid: 16018986
references.citation: Lancet. 2001 Feb 3;357(9253):354-7
references.pmid: 11210998
references.citation: Hum Brain Mapp. 2006 Sep;27(9):766-77
references.pmid: 16317714
references.citation: Addict Behav. 1985;10(2):163-8
references.pmid: 3859990
references.citation: Synapse. 2001 Jan;39(1):58-63
references.pmid: 11071710
references.citation: Neurosci Biobehav Rev. 2008;32(1):20-39
references.pmid: 17617461
references.citation: Nat Neurosci. 2005 Nov;8(11):1481-9
references.pmid: 16251991
references.citation: J Abnorm Psychol. 2008 Nov;117(4):924-35
references.pmid: 19025237
references.citation: J Neurosci. 2008 Dec 24;28(52):14320-8
references.pmid: 19109513
references.citation: J Neurosci. 2006 Jun 14;26(24):6583-8
references.pmid: 16775146
references.citation: Brain. 2001 Sep;124(Pt 9):1720-33
references.pmid: 11522575